Holen Sie sich die Stockscreener-App
2.97
0.00%
0.00
Schlusskurs vom Vortag:
$2.97
Offen:
$3
24-Stunden-Volumen:
36,289
Relative Volume:
0.27
Marktkapitalisierung:
$95.67M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.48M
KGV:
-7.6154
EPS:
-0.39
Netto-Cashflow:
$-7.93M
1W Leistung:
-0.67%
1M Leistung:
-5.71%
6M Leistung:
+0.68%
1J Leistung:
-11.61%
1-Tages-Spanne:
$2.939
$3.0046
1-Wochen-Bereich:
$2.93
$3.20
52-Wochen-Spanne:
$2.07
$4.20
Anixa Biosciences Inc Stock (ANIX) Company Profile
Firmenname
Anixa Biosciences Inc
Sektor
Branche
Telefon
408-708-9808
Adresse
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Vergleichen Sie ANIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
2.97 | 95.67M | 0 | -12.48M | -7.93M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Eingeleitet | Maxim Group | Buy |
| 2022-12-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-04-12 | Eingeleitet | H.C. Wainwright | Buy |
Anixa Biosciences Inc Aktie (ANIX) Neueste Nachrichten
Price momentum metrics for Anixa Biosciences Inc. explainedCPI Data & Low Volatility Stock Recommendations - Newser
Can technical indicators confirm Anixa Biosciences Inc.’s reversalJuly 2025 Price Swings & Accurate Buy Signal Alerts - Newser
Can Anixa Biosciences Inc. expand into new marketsMarket Sentiment Summary & Proven Capital Preservation Tips - خودرو بانک
Can Anixa Biosciences Inc. sustain its profitabilityPortfolio Value Summary & Verified Short-Term Plans - خودرو بانک
Will Anixa Biosciences Inc. benefit from rising consumer demandJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - خودرو بانک
Applying sector rotation models to Anixa Biosciences Inc.Market Activity Recap & Target Return Focused Stock Picks - Newser
Does Anixa Biosciences Inc. show high probability of reboundDividend Hike & Precise Entry and Exit Recommendations - Newser
Real time scanner hits for Anixa Biosciences Inc. explainedMarket Rally & Smart Investment Allocation Tips - Newser
Is Anixa Biosciences Inc. still worth holding after the dip2025 Earnings Surprises & Proven Capital Preservation Methods - Newser
Can Anixa Biosciences Inc. reach all time highs this yearJuly 2025 Update & Reliable Entry Point Trade Alerts - خودرو بانک
Anixa Biosciences Inc. recovery potential after sell offWeekly Risk Summary & Daily Profit Focused Screening - Newser
How to interpret RSI for Anixa Biosciences Inc. stockEarnings Trend Report & Verified Short-Term Trading Plans - Newser
What’s the beta of Anixa Biosciences Inc. stockPortfolio Performance Summary & Low Drawdown Investment Strategies - خودرو بانک
Using RSI to spot recovery in Anixa Biosciences Inc.Options Play & Weekly Breakout Watchlists - Newser
Sector ETF performance correlation with Anixa Biosciences Inc.Portfolio Gains Report & Technical Confirmation Trade Alerts - Newser
Will Anixa Biosciences Inc. outperform during market ralliesJuly 2025 Opening Moves & Verified Swing Trading Watchlists - خودرو بانک
Visual trend scoring systems applied to Anixa Biosciences Inc.Market Movement Recap & Expert Approved Momentum Ideas - Newser
Exit strategy if you’re trapped in Anixa Biosciences Inc.July 2025 Intraday Action & Low Drawdown Investment Strategies - Newser
Anixa Biosciences Inc. Reversal Rally May Surprise Bears2025 Buyback Activity & Weekly Top Stock Performers List - beatles.ru
Using economic indicators to assess Anixa Biosciences Inc. potentialJuly 2025 PostEarnings & Reliable Price Breakout Alerts - Newser
Analyzing recovery setups for Anixa Biosciences Inc. investorsJuly 2025 Price Swings & High Return Trade Guides - Newser
Detecting price anomalies in Anixa Biosciences Inc. with AI2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Anixa Biosciences ANIX 2025Q3 Earnings Preview Downside Risk Amid Persistent Operational Losses - AInvest
Can Anixa Biosciences Inc. continue delivering strong returnsQuarterly Portfolio Review & Safe Capital Growth Tips - خودرو بانک
Leading Cancer Treatment Biotech Anixa Biosciences Set for Key Presentation at Global Investment Conference - Stock Titan
Top chart patterns to watch in Anixa Biosciences Inc.Bond Market & AI Powered Market Trend Analysis - Newser
Anixa Biosciences (NASDAQ:ANIX): Assessing the Feasibility of Sustained Growth Amid Rising Cash Burn - AInvest
Assessing Anixa Biosciences' (NASDAQ:ANIX) Cash Burn and Cash Runway - AInvest
Here's Why We're Not Too Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation - Yahoo Finance
Is Anixa Biosciences Inc. forming higher highs and higher lows2025 Sector Review & Technical Entry and Exit Tips - خودرو بانک
Technical analysis overview for Anixa Biosciences Inc. stockMarket Performance Recap & Low Risk Growth Stock Ideas - Newser
Applying Wyckoff theory to Anixa Biosciences Inc. stock2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Finanzdaten der Anixa Biosciences Inc-Aktie (ANIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anixa Biosciences Inc-Aktie (ANIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KUMAR AMIT | Chief Executive Officer |
Jul 30 '25 |
Buy |
3.16 |
5,000 |
15,800 |
579,925 |
| Baskies Arnold M | Director |
Jul 18 '25 |
Buy |
3.39 |
5,000 |
16,950 |
125,000 |
| Titterton Lewis H jr | Director |
Jul 11 '25 |
Buy |
3.14 |
10,000 |
31,400 |
943,334 |
| KUMAR AMIT | Chief Executive Officer |
Jul 11 '25 |
Buy |
3.15 |
5,000 |
15,750 |
574,925 |
| KUMAR AMIT | Chief Executive Officer |
Jun 04 '25 |
Buy |
2.85 |
10,000 |
28,500 |
569,925 |
| Baskies Arnold M | Director |
Jan 28 '25 |
Buy |
2.82 |
5,000 |
14,100 |
120,000 |
| Titterton Lewis H jr | Director |
Jan 23 '25 |
Buy |
2.91 |
2,000 |
5,820 |
932,334 |
| Titterton Lewis H jr | Director |
Jan 24 '25 |
Buy |
3.00 |
1,000 |
3,000 |
933,334 |
| Titterton Lewis H jr | Director |
Jan 22 '25 |
Buy |
3.01 |
2,000 |
6,020 |
930,334 |
| Titterton Lewis H jr | Director |
Jan 21 '25 |
Buy |
2.59 |
6,000 |
15,540 |
928,334 |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):